World News
-
Bristol-Myers Squibb Board Announces Election of Three New Directors
World | News | 0 Comment | 12 Sep, 2019
Bristol-Myers Squibb Company has announced that its Board of Directors has elected three new independent Directors: Michael Bonney, Dr. Julia A. Haller and Phyllis Yale will join the B...Read more
-
ESC publishes new guidelines to manage diabetes and CCS
World | News | 0 Comment | 10 Sep, 2019
The European Society of Cardiology (ESC) has published new clinical practice guidelines on the management of diabetes and ‘chronic coronary syndromes (CCS)’, which replace the 2...Read more
-
Rivaroxaban ensures superior kidney function preservation benefits for CKD
World | News | 0 Comment | 10 Sep, 2019
New real world evidence (RWE) from the RELOADED and CALLIPER observational studies demonstrate rivaroxaban’s superior benefit in preserving kidney function of atrial fibrillation (AF)...Read more
-
Kaspersky alerts on increasing pharmaceuticals cyber-crimes
World | News | 0 Comment | 10 Sep, 2019
Global cybersecurity company Kaspersky reveals an alarming trend observed in the pharmaceutical industry – a year-on-year steady increase on the number of devices being attacked by cy...Read more
-
World | Analysis | 0 Comment | 10 Sep, 2019
Celgene Corporation’s INREBIC (fedratinib) became the first drug to be approved by the U S Food and Drug Administration (FDA) in nearly a decade for the treatment of myelofibrosi...Read more
-
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
World | News | 0 Comment | 09 Sep, 2019
Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targe...Read more
-
Schrödinger, AstraZeneca join hands to accelerate drug dicovery
World | News | 0 Comment | 05 Sep, 2019
Schrödinger, scientific leader in developing state-of-the-art chemical simulation software, has announced a collaboration with AstraZeneca to deploy Schrödinger’s ...Read more
-
Mundipharma, Cidara ink $568M deal for antifungal treatment
World | News | 0 Comment | 04 Sep, 2019
Cidara Therapeutics, Inc. and Mundipharma have announced that they have entered into a strategic partnership to develop and commercialize rezafungin for the treatment and prevention of inva...Read more
-
Velabs Therapeutics partners with alytas for obesity treatment
World | News | 0 Comment | 03 Sep, 2019
Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeutic antibodies, has announces that it has entered into a partnership agreement...Read more
-
Abbott unveils new detection platform in Brazil
World | News | 0 Comment | 02 Sep, 2019
Abbott, a global health care company, launches in Brazil its ID NOW ™point of care molecular platform with tests for the rapid detection of respiratory diseases su...Read more
-
SC Johnson Spatial repellent innovation provides potential solution for malaria
World | News | 0 Comment | 30 Aug, 2019
The World Health Organization (WHO) recently posted a report showing the effectiveness of spatial repellents in fighting malaria. The data outcomes came from the first study of a five-year ...Read more
-
BioCity invests in early-stage precision medicine biotech
World | News | 0 Comment | 29 Aug, 2019
BioCity, the pioneering life science incubator and business collective, on 29 August 2019, announced an investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precisio...Read more
-
Crozet partners with PHV to develop Nipah virus vaccine
World | News | 0 Comment | 28 Aug, 2019
Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (PHV), to advance the development and manufacture of a vaccine against ...Read more
-
Harbour BioMed, PPD partner for oncology and immunology
World | News | 0 Comment | 28 Aug, 2019
Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company, and Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), ...Read more
-
FDA fast tracks AstraZeneca's FARXIGA
World | News | 0 Comment | 28 Aug, 2019
AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal ...Read more
-
Global Neurorehabilitation devices market to be worth $3.2B by 2024
World | News | 0 Comment | 28 Aug, 2019
The global Neurorehabilitation Devices Market is foreseen to project a notable growth because of the rising prevalence of neurological illnesses. Rising cases of neurological diso...Read more
-
FDA approves new add-on drug to treat Parkinson's disease
World | News | 0 Comment | 28 Aug, 2019
The U.S. Food and Drug Administration, on 27 August 2019, approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson's disease ...Read more
-
KPMG, Thermo Fisher to work on gene interaction with medicines
World | News | 0 Comment | 28 Aug, 2019
KPMG's Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with pharmacogenomics data – information about how genes interact with...Read more
